📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: BioRestorative Therapies

1.1 - Company Overview

BioRestorative Therapies Logo

BioRestorative Therapies

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of cellular-based therapies using cell and tissue protocols, including BRTX-100, an autologous stem cell product for chronic lower back pain due to degenerative disc disease, and ThermoStem, a brown adipose-derived stem cell program to generate new brown fat targeting obesity and metabolic disorders; also conducts clinical trials, including a Phase 2 trial for BRTX-100.

Products and services

  • BRTX-100: An autologous stem cell product engineered to treat chronic lower back pain from degenerative disc disease by harvesting, culturing, and injecting the patient’s own cells into the affected disc
  • Clinical Trials: BioRestorative Therapies conducts Phase 2 clinical trials evaluating safety and efficacy of stem cell-based treatments for conditions like chronic lumbar disc disease, centered on BRTX-100
  • ThermoStem: A brown adipose-derived stem cell program developed to generate new brown fat tissue to target obesity and metabolic disorders by potentially increasing metabolism and facilitating weight loss

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to BioRestorative Therapies

Baronova Logo

Baronova

HQ: United States Website
  • Description: Provider of clinical-stage medical devices under development to induce weight loss through non-surgical, non-pharmacologic approaches.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Baronova company profile →
Affymax Logo

Affymax

HQ: United States Website
  • Description: Provider of biopharmaceutical solutions.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Affymax company profile →
InteKrin Therapeutics Logo

InteKrin Therapeutics

HQ: United States Website
  • Description: Provider of clinical-stage biopharmaceutical development and commercialization of breakthrough therapeutics targeting neuroendocrine, metabolic, and immune disorders, addressing diseases such as diabetes, metabolic syndrome, and cancer.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full InteKrin Therapeutics company profile →
Rare Thyroid Therapeutics Logo

Rare Thyroid Therapeutics

HQ: Sweden Website
  • Description: Provider of late-stage orphan drug development.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Rare Thyroid Therapeutics company profile →
Verlyx Logo

Verlyx

HQ: Canada Website
  • Description: Provider of liver-targeting therapeutic agents for the treatment of liver diseases, including lead product VLX103, a proprietary form of pentamidine combining hepatoselective and hepatoprotective properties. Privately held pharmaceutical company.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Verlyx company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for BioRestorative Therapies

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to BioRestorative Therapies

2.2 - Growth funds investing in similar companies to BioRestorative Therapies

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for BioRestorative Therapies

4.2 - Public trading comparable groups for BioRestorative Therapies

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to BioRestorative Therapies

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About BioRestorative Therapies

What does BioRestorative Therapies do?

BioRestorative Therapies is a provider of cellular-based therapies using cell and tissue protocols, including BRTX-100, an autologous stem cell product for chronic lower back pain due to degenerative disc disease, and ThermoStem, a brown adipose-derived stem cell program to generate new brown fat targeting obesity and metabolic disorders; also conducts clinical trials, including a Phase 2 trial for BRTX-100.

Who are BioRestorative Therapies's competitors?

BioRestorative Therapies's competitors and similar companies include Baronova, Affymax, InteKrin Therapeutics, Rare Thyroid Therapeutics, and Verlyx.

Where is BioRestorative Therapies headquartered?

BioRestorative Therapies is headquartered in United States.

How many employees does BioRestorative Therapies have?

BioRestorative Therapies has 1,000 employees 🔒.

When was BioRestorative Therapies founded?

BioRestorative Therapies was founded in 2010 🔒.

What sector and industry vertical is BioRestorative Therapies in?

BioRestorative Therapies is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for BioRestorative Therapies

Who are the top strategic acquirers in BioRestorative Therapies's sector and industry

Top strategic M&A buyers and acquirers in BioRestorative Therapies's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for BioRestorative Therapies?

Top strategic M&A buyers groups and sectors for BioRestorative Therapies include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in BioRestorative Therapies's sector and industry vertical

Which are the top PE firms investing in BioRestorative Therapies's sector and industry vertical?

Top PE firms investing in BioRestorative Therapies's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in BioRestorative Therapies's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in BioRestorative Therapies's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in BioRestorative Therapies's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to BioRestorative Therapies include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in BioRestorative Therapies's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for BioRestorative Therapies?

The key public trading comparables and valuation benchmarks for BioRestorative Therapies include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for BioRestorative Therapies for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for BioRestorative Therapies with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in BioRestorative Therapies's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for BioRestorative Therapies with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in BioRestorative Therapies's' sector and industry vertical?

Access recent funding rounds and capital raises in BioRestorative Therapies's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for BioRestorative Therapies